111 (YI) Gains from Sales and Divestitures (2019 - 2025)

111's (YI) quarterly Gains from Sales and Divestitures came in at $351065.7 in Q4 2025, up 53.95% year-on-year from $228039.8 in Q4 2024, and up 53.95% quarter-over-quarter from $228039.8 in Q4 2024.

111 (YI) Gains from Sales and Divestitures (2019 - 2025) Analysis & Trends

111 has disclosed Gains from Sales and Divestitures across 7 years of filings, most recently posting $351065.7 for Q4 2025.

  • Gains from Sales and Divestitures for Q4 2025 came in at $351065.7, up 53.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $351065.7 (up 53.95% YoY), and the FY2025 annual result was $346484.8, up 51.99% from the prior year.
  • Gains from Sales and Divestitures came in at $351065.7 for Q4 2025 at 111, up from $228039.8 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $351065.7 in Q4 2025 to a low of $117719.1 in Q4 2022.
  • The 5-year median for Gains from Sales and Divestitures is $139984.7 (2021), against an average of $191448.1.
  • Across the five-year window, Gains from Sales and Divestitures fell 15.91% in 2022 and jumped 89.35% in 2024, its largest moves.
  • 111's Gains from Sales and Divestitures stood at $139984.7 in 2021, then fell by 15.91% to $117719.1 in 2022, then grew by 2.3% to $120431.5 in 2023, then surged by 89.35% to $228039.8 in 2024, then jumped by 53.95% to $351065.7 in 2025.
  • The last three Gains from Sales and Divestitures figures came in at $351065.7 (Q4 2025), $228039.8 (Q4 2024), and $120431.5 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Akso Health 2,315,158.81 Bn 2,315,158.63 Bn -
2 Mckesson 92.76 Bn 89.18 Bn 4.04 Bn
3 Cencora 52.82 Bn 50.83 Bn 3.59 Bn
4 Cardinal Health 52.17 Bn 48.39 Bn 2.50 Bn
5 Henry Schein 9.19 Bn 9.71 Bn 1.07 Bn
6 Accendra Health 246.88 Mn -90.00 Mn 312.39 Mn
7 Edap Tms 161.92 Mn 146.92 Mn 8.15 Mn
8 111 107.47 Mn 25.61 Mn 23.58 Mn
9 Cosmos Health 9.42 Mn 7.26 Mn 1.38 Mn
10 Cellyan Biotechnology 5.69 -2.48 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 351,065.65
Dec 31, 2025 351,065.65
Dec 31, 2024 228,039.80
Dec 31, 2024 228,039.80
Dec 31, 2023 120,431.48
Dec 31, 2023 120,431.48
Dec 31, 2022 117,719.08
Dec 31, 2022 117,719.08
Dec 31, 2021 139,984.71
Dec 31, 2021 139,984.71
Dec 31, 2020 96,277.77
Dec 31, 2020 96,277.77
Mar 31, 2020 30,086.70
Mar 31, 2020 30,086.70
Dec 31, 2019 42,738.46
Dec 31, 2019 42,738.46